Alvotech (NASDAQ:ALVOW – Get Free Report) was the target of a large growth in short interest in the month of October. As of October 15th, there was short interest totaling 1,309 shares, a growth of 60.6% from the September 30th total of 815 shares. Based on an average daily trading volume, of 1,621 shares, the days-to-cover ratio is currently 0.8 days.
Alvotech Price Performance
ALVOW stock traded up $0.05 during trading on Monday, hitting $0.30. The company had a trading volume of 354 shares, compared to its average volume of 4,535. The company has a fifty day moving average price of $0.36 and a two-hundred day moving average price of $0.30. Alvotech has a fifty-two week low of $0.12 and a fifty-two week high of $1.50.
About Alvotech
Alvotech is a biotechnology company focused on developing and manufacturing biosimilar medicines. Biosimilars are biologic products designed to be highly similar to approved reference medicines and may provide additional treatment options in areas with significant healthcare costs. The company’s portfolio targets therapeutic categories including immunology, ophthalmology, oncology and other chronic conditions.
Alvotech operates an integrated business model that covers biosimilar research, cell-line development, process development, clinical testing and commercial-scale manufacturing.
Further Reading
- Five stocks we like better than Alvotech
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
- 3 Waste Services Stocks With More Growth Than You Might Expect
- Alphabet’s $400 Billion Sell-Off Could Be the Best AI Buying Window Left in 2026
- 3 Tech Stocks Boosting Buyback Capacity in the Face of the Sector’s Recent Tumble
Receive News & Ratings for Alvotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alvotech and related companies with MarketBeat.com's FREE daily email newsletter.
